Complex Application Of Peptides For The Prevention Of Fast Ovarian Aging
In Women In The Second Half Of The Reproductive Period
Background
This study aimed to improve the standard treatment of fast ovarian aging by using low molecular weight
peptide medications containing ovarian and pineal gland peptides.
Methods
We have conducted a study of the effectiveness of treatment in 276 women with reduced reproductive
function aged between 34-38 years. The study of the effectiveness of the peptide complex was conducted
in September 2013 — June 2018 in the Moscow office of the Center of Revitalization and Health.
All patients were The first group: 62 women who received placebo without any
divided into hormonal therapy. 12 groups: The second group: 214 women who received a complex con
taining ovarian peptides Zhenoluten, and a complex containing
pineal gland peptides Endoluten, without any hormonal therapy. 2
From this research, we exclude the following women with: irregular menstruation, chronic adnexitis, poly
cystic ovaries, endometriosis, obstruction of the fallopian tubes, uterine myoma, autoimmune thyroiditis,
pituitary microadenoma, insignificant increase in prolactin, and hypothalamic syndrome.
All peptide medications used in this study were developed by the St. Petersburg Institute of Bioregu
lation and Gerontology and are essentially complexes of peptides with a molecular weight up to 5000
Da, isolated from organs and tissues of young animals. The rationale for this study is based on the data
provided by the study of the effectiveness of drugs obtained previously.
Zhenoluten has a tissue-specific regulatory effect on the tissue cells of the ovaries. It affects metabolic
processes, reduces the severity of pathological changes in the ovaries, normalizes ovarian hormone levels
in the blood, and reduces the risk of developing a number of secondary lesions.
Endoluten has a tissue-specific regulatory effect on the pineal gland cells, normalizes the synthesis and
release of endogenous melatonin, which is manifested in the normalization of the nervous, endocrine,
reproductive and immune systems. It restores lipid and carbohydrate metabolism and has anti-athero
genic, anti-diabetic, and anti-autoimmune effects.
The prescribed complex of peptides:
Zhenoluten — 2 capsules per day for 4 months.
Endoluten — 1 capsule in the morning (1 time in 72 hours) for 4 months.
It is advisable to repeat courses of treatment every 6 months.
We measured:
• indicators of the ovarian hormone levels;
• indicators of ultrasonography of ovaries.
Gothenburg, Sweden 2019
Для таблиц, дозировок и примечаний сверяйтесь с оригинальным PDF: при извлечении текста порядок колонок может измениться.
Из библиотеки Peptides. Авторство и содержание оригинала сохранены. Размещено с разрешения поставщика.